Sodium Chloride (NaCl) 0.9 %: clinical trials recruiting now
3
Recruiting trials
9
Conditions studied
17
US states with sites
3
Countries
Phase breakdown
Phase 2 1
Phase 4 1
Not applicable 1
Conditions being studied
| Condition | Trials |
|---|---|
| Allergies | 1 |
| COPD | 1 |
| Chronic Obstructive Pulmonary Disease (COPD) | 1 |
| Hypertension | 1 |
| Iron Deficiency | 1 |
| Pulmonary Hypertension | 1 |
| SCD | 1 |
| Sickle cell disease | 1 |
| Vaso Occlussive Crisis | 1 |
Recruiting trials involving Sodium Chloride (NaCl) 0.9 %
- Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Efficacy of Liberal Versus Restricted IV Fluid Approach in the Management of Sickle Cell Vaso-Occlusive Crisis
- The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension
Common questions
How many recruiting trials involve Sodium Chloride (NaCl) 0.9 %?
3 recruiting trials across 9 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.